- Home
- DHR vs TMO Comparison
DHR vs TMO Comparison
Compare DHR & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DHR | TMO |
|---|---|---|
| Founded | 1969 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.7B | 216.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DHR | TMO |
|---|---|---|
| Price | $241.70 | $635.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 19 |
| Target Price | $250.53 | ★ $637.78 |
| AVG Volume (30 Days) | ★ 2.7M | 2.0M |
| Earning Date | 01-28-2026 | 01-29-2026 |
| Dividend Yield | ★ 0.55% | 0.28% |
| EPS Growth | N/A | ★ 8.54 |
| EPS | 4.87 | ★ 17.32 |
| Revenue | $24,268,000,000.00 | ★ $43,736,000,000.00 |
| Revenue This Year | $3.75 | $4.33 |
| Revenue Next Year | $4.06 | $5.05 |
| P/E Ratio | $48.15 | ★ $35.75 |
| Revenue Growth | 2.21 | ★ 3.22 |
| 52 Week Low | $171.00 | $385.46 |
| 52 Week High | $258.23 | $629.87 |
Technical Indicators
Market Signals| Indicator | DHR | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 63.18 | 68.53 |
| Support Level | $231.10 | $606.00 |
| Resistance Level | $240.42 | $629.87 |
| Average True Range (ATR) | 5.71 | 16.26 |
| MACD | 0.08 | 2.01 |
| Stochastic Oscillator | 97.65 | 98.43 |
Price Performance
Historical ComparisonAbout DHR Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).